Festive Flu & COVID: Prepare & Protect This Season

Ireland is bracing for a potentially severe influenza season, arriving weeks earlier than usual and driven by a resurgent H3N2 strain. This isn’t simply a return to pre-pandemic norms; the confluence of factors – low population immunity to this specific strain, a healthcare system already strained by overcrowding, and concerningly low vaccination rates among healthcare workers – suggests a challenging winter ahead, with implications extending beyond respiratory illness to cardiovascular health and even cognitive function.

  • Early & Aggressive Strain: The H3N2 virus, similar to the 1968 Hong Kong flu variant, is circulating early and is proving particularly virulent.
  • Healthcare System Under Pressure: A surge in flu cases is exacerbating existing overcrowding in emergency departments, with hospitals already operating at capacity.
  • Vaccination Gap: Despite free access, vaccine uptake remains suboptimal, particularly among healthcare staff, potentially undermining both their protection and patient safety.

The current situation represents a significant shift from recent years, where the H1N1 strain dominated. The relative absence of H3N2 in recent seasons has resulted in diminished population immunity, making more people susceptible to infection. This is compounded by the fact that influenza isn’t merely a respiratory ailment. As Professor Ronan Collins highlights, it carries significant cardiovascular risks, increasing the likelihood of stroke, and can even trigger delirium or accelerate the onset of dementia in vulnerable individuals. The HPSC data reveals a concerning trend: 2,944 confirmed cases and 657 hospitalizations in a single week, with 7,506 cases reported since the season began. These numbers are already exceeding those seen in the past few years, and are mirroring a worrying surge in cases across the UK, where authorities are preparing for a “worst-case scenario.”

The impact isn’t limited to those directly infected. Up to 75% of individuals can be asymptomatic carriers, unknowingly spreading the virus. This silent transmission underscores the importance of preventative measures, and the critical role vaccination plays in curbing the spread. However, the government’s acknowledgement that over three-quarters of hospitalized flu patients are unvaccinated highlights a persistent challenge in public health messaging and vaccine acceptance. The low uptake among healthcare workers – currently at 45% – is particularly alarming, given their frontline role and the potential for nosocomial (hospital-acquired) infections. The Irish Patients Association rightly points to evidence demonstrating that vaccinating healthcare workers significantly reduces patient mortality.

Further complicating matters is the HSE’s decision not to offer the enhanced flu vaccine for over 65s, citing cost concerns. While the standard vaccine is WHO-approved, recent reports suggest potential limitations in its effectiveness against the circulating strain. This decision raises questions about resource allocation and the potential long-term cost savings of preventative measures versus the expense of treating severe cases and managing hospital overcrowding. The fact that ten countries *do* offer the enhanced vaccine to this age group adds weight to this debate.

The Forward Look

The next few weeks are critical. The flu season typically peaks around Christmas and New Year’s, meaning hospitals will likely face even greater pressure as planned surgeries are postponed and emergency departments become increasingly congested. We can anticipate further strain on an already overburdened system, potentially leading to longer wait times and compromised patient care. The Medical Council’s recent emphasis on healthcare workers’ ethical responsibilities regarding vaccination suggests a potential push for mandatory vaccination policies in the future, a move that would likely be met with resistance but could prove essential for protecting both staff and patients. Looking beyond this season, the HSE needs to reassess its cost-benefit analysis regarding the enhanced vaccine for older adults. The potential for a more severe season, coupled with the documented benefits of the enhanced vaccine, may necessitate a shift in policy. Finally, a sustained effort to improve vaccination rates among healthcare workers is paramount, requiring a multi-faceted approach that addresses concerns, promotes education, and potentially implements incentives or, ultimately, mandates. The current situation serves as a stark reminder that investing in preventative public health measures is not merely a matter of cost, but a matter of safeguarding the health and well-being of the population.

Worth a look


Discover more from Archyworldys

Subscribe to get the latest posts sent to your email.